Funder: MEIJI PHARMA SPAIN, S.A.
date_range Duration: from 01 June 2009 to 31 December 2010 (19 months)
euro 24,545.45 EUR

Of Regional scope.

Estudio comparativo de Condroitin sulfato PHARMA LICENCE vs CHONDROSULF® 400 mg".

Former participants (7)